Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging

Multiplexed tissue imaging enables precise, spatially resolved enumeration and characterization of cell types and states in human resection specimens. A growing number of methods applicable to formalin-fixed, paraffin-embedded (FFPE) tissue sections have been described, the majority of which rely on antibodies for antigen detection and mapping. This protocol provides step-by-step procedures for confirming the selectivity and specificity of antibodies used in fluorescence-based tissue imaging and for the construction and validation of antibody panels. Although the protocol is implemented using tissue-based cyclic immunofluorescence (t-CyCIF) as an imaging platform, these antibody-testing methods are broadly applicable. We demonstrate assembly of a 16-antibody panel for enumerating and localizing T cells and B cells, macrophages, and cells expressing immune checkpoint regulators. The protocol is accessible to individuals with experience in microscopy and immunofluorescence; some experience in computation is required for data analysis. A typical 30-antibody dataset for 20 FFPE slides can be generated within 2 weeks.This protocol provides guidelines for designing and validating antibody panels for fluorescence-based imaging of FFPE tissue sections using cyclic immunofluorescence (t-CyCIF) or other multiplexed imaging methods.

[1]  Jennifer C. Waters,et al.  Accuracy and precision in quantitative fluorescence microscopy , 2009 .

[2]  Daniel Zelterman,et al.  Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma , 2019, Clinical Cancer Research.

[3]  D. Klatzmann,et al.  Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy , 2015, Front. Immunol..

[4]  Michael B. Stadler,et al.  An Immune Atlas of Clear Cell Renal Cell Carcinoma , 2017, Cell.

[5]  C. Sotiriou,et al.  An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers , 2016, Breast Cancer Research.

[6]  Samir Kumar-Singh,et al.  Antibody Elution Method for Multiple Immunohistochemistry on Primary Antibodies Raised in the Same Species and of the Same Subtype , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  W. Schubert,et al.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.

[8]  Helen M. Moore,et al.  Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. , 2011, Archives of pathology & laboratory medicine.

[9]  B. Scholkopf,et al.  Fisher discriminant analysis with kernels , 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468).

[10]  D. Hicks,et al.  The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research , 2012, Biotechnic & Histochemistry.

[11]  M. Salto‐Tellez,et al.  Standardising RNA profiling based biomarker application in cancer-The need for robust control of technical variables. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[12]  M. Uhlik,et al.  High-content multiplexed tissue imaging and quantification for cancer drug discovery. , 2013, Drug discovery today.

[13]  P. Deb.  Finite Mixture Models , 2008 .

[14]  George M. Church,et al.  Highly Multiplexed Subcellular RNA Sequencing in Situ , 2014, Science.

[15]  D. Grignon,et al.  Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions: Report From the International Society of Urologic Pathology Consensus Conference , 2014, The American journal of surgical pathology.

[16]  J. Todd,et al.  Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry , 2010, Nature Protocols.

[17]  Peter K. Sorger,et al.  Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method , 2015, Nature Communications.

[18]  Christopher M. Jackson,et al.  Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas , 2016, Clinical Cancer Research.

[19]  D. Carbone,et al.  First-Line Nivolumab in Stage IV or Recurrent Non-Small Cell Lung Cancer , 2017 .

[20]  T. Hauling,et al.  In Situ Single-Molecule RNA Genotyping Using Padlock Probes and Rolling Circle Amplification. , 2017, Methods in molecular biology.

[21]  Kurt A. Schalper,et al.  Quantitative Measurement of Cancer Tissue Biomarkers in the Lab and in the Clinic , 2014, Laboratory Investigation.

[22]  Sandro Santagata,et al.  Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade. , 2018, JCO precision oncology.

[23]  Sean C. Bendall,et al.  viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.

[24]  J. Dobrucki,et al.  Method of calibration of a fluorescence microscope for quantitative studies , 2011, Journal of microscopy.

[25]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[26]  David A Schiffmann,et al.  Open microscopy environment and findspots: integrating image informatics with quantitative multidimensional image analysis. , 2006, BioTechniques.

[27]  Christoph Meinel,et al.  Deep Learning for Medical Image Analysis , 2018, Journal of Pathology Informatics.

[28]  B. Zhu,et al.  T-cell exhaustion in the tumor microenvironment , 2015, Cell Death and Disease.

[29]  K. Dobbin,et al.  Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation , 2016, Journal of Immunotherapy for Cancer.

[30]  Yasunori Sato,et al.  Study Designs and Statistical Analyses for Biomarker Research , 2012, Sensors.

[31]  Walter Schubert,et al.  Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures , 2007, Nature Protocols.

[32]  Jason A Papin,et al.  Simple: A Sequential Immunoperoxidase Labeling and Erasing Method , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  Douglas A. Creager,et al.  The Open Microscopy Environment (OME) Data Model and XML file: open tools for informatics and quantitative analysis in biological imaging , 2005, Genome Biology.

[34]  Jeffrey R Moffitt,et al.  High-performance multiplexed fluorescence in situ hybridization in culture and tissue with matrix imprinting and clearing , 2016, Proceedings of the National Academy of Sciences.

[35]  George G Klee,et al.  Antibody-based protein multiplex platforms: technical and operational challenges. , 2010, Clinical chemistry.

[36]  Demin Li,et al.  The European antibody network's practical guide to finding and validating suitable antibodies for research , 2015, mAbs.

[37]  Lloyd J. Old,et al.  CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer , 2007, Clinical Cancer Research.

[38]  L. Weiss,et al.  A Single Slide Multiplex Assay for the Evaluation of Classical Hodgkin Lymphoma , 2014, The American journal of surgical pathology.

[39]  Jason A. Papin,et al.  A Sequential Immunoperoxidase Labeling and Erasing Method , 2010 .

[40]  S. S. Wilks.  The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses , 1938 .

[41]  M. Millenson,et al.  PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. , 2015, The New England journal of medicine.

[42]  L. True.  Methodological requirements for valid tissue-based biomarker studies that can be used in clinical practice , 2014, Virchows Archiv.

[43]  Peter Vogel,et al.  Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape , 2022 .

[44]  Chris Allan,et al.  Open tools for storage and management of quantitative image data. , 2008, Methods in cell biology.

[45]  Matthew L Albert,et al.  New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue , 2019, The Journal of pathology.

[46]  Ken S Lau,et al.  Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity. , 2017, JCI insight.

[47]  Sean C. Bendall,et al.  A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging , 2018, Cell.

[48]  Sandro Santagata,et al.  Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes , 2018, eLife.

[49]  Bernd Bodenmiller,et al.  Multiplexed Epitope-Based Tissue Imaging for Discovery and Healthcare Applications. , 2016, Cell systems.

[50]  G. Freeman,et al.  Coinhibitory Pathways in Immunotherapy for Cancer. , 2016, Annual review of immunology.

[51]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[52]  Federico Cappuzzo,et al.  Atezolizumab for First‐Line Treatment of Metastatic Nonsquamous NSCLC , 2018, The New England journal of medicine.

[53]  Yin Cai,et al.  Generation and validation of homozygous fluorescent knock-in cells using CRISPR–Cas9 genome editing , 2018, Nature Protocols.

[54]  L. Gandhi,et al.  Emerging biomarkers for immune checkpoint inhibition in lung cancer. , 2018, Seminars in cancer biology.

[55]  Emma Lundberg,et al.  A proposal for validation of antibodies , 2016, Nature Methods.

[56]  Walter Schubert,et al.  Large molecular systems landscape uncovers T cell trapping in human skin cancer , 2016, Scientific Reports.

[57]  Ewert Bengtsson,et al.  Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei. , 2002, Cytometry.

[58]  R. Fisher.  THE USE OF MULTIPLE MEASUREMENTS IN TAXONOMIC PROBLEMS , 1936 .

[59]  R. A. Willis.  The Borderland of Embryology and Pathology , 1950, Bulletin of the New York Academy of Medicine.

[60]  Chuanwu Wang,et al.  Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets , 2011, BMC Immunology.

[61]  Erik Brauner,et al.  Informatics and Quantitative Analysis in Biological Imaging , 2003, Science.

[62]  Sucheendra K. Palaniappan,et al.  Systemic immune response profiling with SYLARAS implicates a role for CD45R/B220+ CD8+ T cells in glioblastoma immunology , 2019, bioRxiv.

[63]  M. Nilsson,et al.  Padlock Probes to Detect Single Nucleotide Polymorphisms. , 2018, Methods in molecular biology.

[64]  E. Petricoin,et al.  Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variability , 2009, Proteomics. Clinical applications.

[65]  Carolina Wählby,et al.  In situ sequencing for RNA analysis in preserved tissue and cells , 2013, Nature Methods.

[66]  B. Alexander,et al.  Meningioma transcription factors link cell lineage with systemic metabolic cues , 2018, Neuro-oncology.

[67]  T. Dubovik,et al.  Mass cytometry analysis of immune cells in the brain , 2018, Nature Protocols.

[68]  Jennifer C. Waters,et al.  Accuracy and precision in quantitative fluorescence microscopy , 2009, The Journal of cell biology.

[69]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[70]  Alan Dove,et al.  Technology Feature | Agreeable antibodies: Antibody validation challenges and solutions , 2017 .

[71]  David C. Smith,et al.  Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  Daniel J Sargent,et al.  Predictive biomarker validation in practice: lessons from real trials , 2010, Clinical trials.

[73]  Edward S Boyden,et al.  Rapid Sequential in Situ Multiplexing With DNA-Exchange-Imaging , 2017, bioRxiv.

[74]  Lassi Paavolainen,et al.  Data-analysis strategies for image-based cell profiling , 2017, Nature Methods.

[75]  Oren Z. Kraus,et al.  Machine learning and computer vision approaches for phenotypic profiling , 2017, The Journal of cell biology.

[76]  Bernd Bodenmiller,et al.  Systematic analysis of cell phenotypes and cellular social networks in tissues using the histology topography cytometry analysis toolbox (histoCAT) , 2017, bioRxiv.

[77]  Qing Li,et al.  Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue , 2013, Proceedings of the National Academy of Sciences.

[78]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[79]  G. Litjens,et al.  In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide , 2016, Science Immunology.

[80]  R. Coffey,et al.  Interpreting heterogeneity in intestinal tuft cell structure and function. , 2018, The Journal of clinical investigation.

[81]  Sean C. Bendall,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[82]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[83]  Sudhir Srivastava,et al.  The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities. , 2018, Trends in cancer.

[84]  Monika S. Kowalczyk,et al.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.

[85]  Ola Söderberg,et al.  In situ detection and genotyping of individual mRNA molecules , 2010, Nature Methods.

[86]  Adam A. Margolin,et al.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. , 2017, Cell reports.

[87]  Joseph T. Roland,et al.  Unsupervised Trajectory Analysis of Single-Cell RNA-Seq and Imaging Data Reveals Alternative Tuft Cell Origins in the Gut. , 2017, Cell systems.

[88]  Bernd Bodenmiller,et al.  miCAT: A toolbox for analysis of cell phenotypes and interactions in multiplex image cytometry data , 2017, Nature Methods.

[89]  Valsamo Anagnostou,et al.  Antibody validation. , 2010, BioTechniques.

[90]  T. Scherer,et al.  Cluster Size and Quinary Structure Determine the Rheological Effects of Antibody Self-Association at High Concentrations. , 2018, The journal of physical chemistry. B.

[91]  Y. Kluger,et al.  Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time , 2015, Laboratory Investigation.

[92]  K. Kelly,et al.  Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial. , 2017, The Lancet. Oncology.

[93]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[94]  Stephen Broderick,et al.  Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer , 2018, The New England journal of medicine.

[95]  X. Zhuang,et al.  Spatially resolved, highly multiplexed RNA profiling in single cells , 2015, Science.

[96]  Alan Dove,et al.  Agreeable antibodies: Antibody validation challenges and solutions , 2017 .

[97]  B. Delahunt,et al.  Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology: Report From the International Society of Urological Pathology Consensus Conference , 2014, The American journal of surgical pathology.

[98]  Microfluidic Tissue Mesodissection in Molecular Cancer Diagnostics , 2017, SLAS technology.

[100]  Sandro Santagata,et al.  Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma , 2018, Neuro-oncology.

[101]  Sean C. Bendall,et al.  Multiplexed ion beam imaging of human breast tumors , 2014, Nature Medicine.

[102]  Patrik L. Ståhl,et al.  Visualization and analysis of gene expression in tissue sections by spatial transcriptomics , 2016, Science.

[103]  Fiona Ginty,et al.  Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. , 2016, JCI insight.

[104]  Lloyd J. Old,et al.  Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer , 2010, Proceedings of the National Academy of Sciences.

[105]  G. Nolan,et al.  Automated Mapping of Phenotype Space with Single-Cell Data , 2016, Nature Methods.

[106]  P. Sharma,et al.  Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential , 2015, Cell.

[107]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .

[108]  Bernd Bodenmiller,et al.  Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry , 2017, Cell systems.

[109]  Soonmyung Paik,et al.  Use of archived specimens in evaluation of prognostic and predictive biomarkers. , 2009, Journal of the National Cancer Institute.

[110]  J. Allison,et al.  Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. , 2018, Cancer discovery.

[111]  Kun Zhang,et al.  Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues , 2015, Nature Protocols.

[112]  G. Linette,et al.  Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. , 2015, The Lancet. Oncology.

[113]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[114]  Eva Mezey,et al.  Simultaneous Visualization of Multiple Antigens with Tyramide Signal Amplification using Antibodies from the same Species , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[115]  Sandro Santagata,et al.  Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes , 2018 .

[116]  Salil S. Bhate,et al.  Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging , 2017, Cell.

[117]  Leida Zhang,et al.  Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. , 2010, Human immunology.

[118]  Benjamin D. Greenbaum,et al.  Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses , 2017, Cell.